Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.

about

RANK as a therapeutic target in cancer.Preparation of Murine Submandibular Salivary Gland for Upright Intravital Microscopy.

P2860

Q38691526-074FAB2E-6F6A-4885-B755-EE657A4B8EC3 Q54204527-1177129E-C4A6-4EB8-96CD-185E5F677A9F

P2860

Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.

Item

http://www.wikidata.org/entity/Q35659971

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.

@ast

Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.

@en

type

Item

label

Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.

@ast

Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.

@en

prefLabel

Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.

@ast

Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.

@en

P1476

Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.

@en

P2093

Allison P Jacob

http://www.w3.org/2001/XMLSchema#string

John P Lydon

http://www.w3.org/2001/XMLSchema#string

Maria M Szwarc

http://www.w3.org/2001/XMLSchema#string

Michael M Ittmann

http://www.w3.org/2001/XMLSchema#string

William C Dougall

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

Molecular mechanisms of epithelial-mesenchymal transition

Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis

Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

RANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro

Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland.

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.

P304

e0128467

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0128467

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ramakrishna Kommagani

P577

2015-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278043772

http://www.w3.org/2001/XMLSchema#string

P698

26061636

http://www.w3.org/2001/XMLSchema#string

P932

4464738

http://www.w3.org/2001/XMLSchema#string

Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.

about

P2860

P2860

Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932